Lucía Trilla-Fuertes

15PUBLICATIONS
45CO-AUTHORS
Molecular targetsPredictive and prognostic markersProgramming languagesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 27, 2026
NKGD2 Ligands (NKG2DLs) in Breast Cancer: In Silico Analysis and Narrative Review.

Jesús Peña-López, Angelo Gámez-Pozo, Lucía Trilla-Fuertes

|Jan 10, 2026
Identification of a Muscle-Invasive Bladder Carcinoma Molecular Subtype of Poor Responders to Neoadjuvant Chemotherapy and High Expression of Targetable Biomarkers.

Lucía Trilla-Fuertes, Jorge Pedregosa-Barbas, Eugenia García-Fernández

|May 07, 2025
A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study.

Álvaro Pinto-Marín, Lucía Trilla-Fuertes, Jesús Miranda Poma

|Nov 09, 2024
Layer Analysis Based on RNA-Seq Reveals Molecular Complexity of Gastric Cancer.

Pablo Perez-Wert, Sara Fernandez-Hernandez, Angelo Gamez-Pozo

|Mar 15, 2024
Functional proteomics of colon cancer Consensus Molecular Subtypes.

Jaime Feliu, Angelo Gámez-Pozo, Daniel Martínez-Pérez

|Sep 09, 2023
Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.

Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez

Pageof 3